Marken has been granted a 12-year license to ship biological samples and drug product within China. The company has also grown its presence in China, adding staff trained and certified on IATA regulations and anti-corruption policies. Marken has also initiated its Phase II depot roll out plan with the construction of its pharmaceutical depot near the Beijing International airport.   Wes Wheeler, chief executive officer of Marken, said, “We recognize the value of the clinical trial market i...